ATRION CORPORATION (ATRI) Stock Fundamental Analysis
NASDAQ:ATRI - Nasdaq - US0499041053 - Common Stock - Currency: USD
We assign a fundamental rating of 5 out of 10 to ATRI. ATRI was compared to 188 industry peers in the Health Care Equipment & Supplies industry. While ATRI has a great health rating, its profitability is only average at the moment. ATRI is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ATRI was profitable.
ATRI had a positive operating cash flow in the past year.
ATRI had positive earnings in each of the past 5 years.
Each year in the past 5 years ATRI had a positive operating cash flow.
1.2 Ratios
The Return On Assets of ATRI (4.82%) is better than 82.72% of its industry peers.
With a decent Return On Equity value of 5.26%, ATRI is doing good in the industry, outperforming 77.49% of the companies in the same industry.
The Return On Invested Capital of ATRI (5.13%) is better than 78.53% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ATRI is above the industry average of 7.89%.
The last Return On Invested Capital (5.13%) for ATRI is well below the 3 year average (11.35%), which needs to be investigated, but indicates that ATRI had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.82% | ||
| ROE | 5.26% | ||
| ROIC | 5.13% |
ROA(3y)11.02%
ROA(5y)11.82%
ROE(3y)12.05%
ROE(5y)13%
ROIC(3y)11.35%
ROIC(5y)12.04%
1.3 Margins
ATRI's Profit Margin of 6.92% is fine compared to the rest of the industry. ATRI outperforms 78.53% of its industry peers.
In the last couple of years the Profit Margin of ATRI has declined.
With a decent Operating Margin value of 7.93%, ATRI is doing good in the industry, outperforming 75.39% of the companies in the same industry.
ATRI's Operating Margin has declined in the last couple of years.
ATRI has a Gross Margin of 32.08%. This is in the lower half of the industry: ATRI underperforms 72.25% of its industry peers.
In the last couple of years the Gross Margin of ATRI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.93% | ||
| PM (TTM) | 6.92% | ||
| GM | 32.08% |
OM growth 3Y-18%
OM growth 5Y-13.39%
PM growth 3Y-19.22%
PM growth 5Y-12.62%
GM growth 3Y-6.34%
GM growth 5Y-4.8%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ATRI is still creating some value.
Compared to 1 year ago, ATRI has less shares outstanding
The number of shares outstanding for ATRI has been reduced compared to 5 years ago.
There is no outstanding debt for ATRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
ATRI has an Altman-Z score of 25.99. This indicates that ATRI is financially healthy and has little risk of bankruptcy at the moment.
ATRI's Altman-Z score of 25.99 is amongst the best of the industry. ATRI outperforms 95.29% of its industry peers.
ATRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 25.99 |
ROIC/WACC0.59
WACC8.7%
2.3 Liquidity
ATRI has a Current Ratio of 6.80. This indicates that ATRI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.80, ATRI belongs to the best of the industry, outperforming 81.68% of the companies in the same industry.
A Quick Ratio of 2.94 indicates that ATRI has no problem at all paying its short term obligations.
ATRI has a better Quick ratio (2.94) than 61.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.8 | ||
| Quick Ratio | 2.94 |
3. Growth
3.1 Past
ATRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.54%.
The Earnings Per Share has been decreasing by -9.39% on average over the past years.
The Revenue has been growing slightly by 6.00% in the past year.
ATRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.13% yearly.
EPS 1Y (TTM)-53.54%
EPS 3Y-14.81%
EPS 5Y-9.39%
EPS Q2Q%-93.89%
Revenue 1Y (TTM)6%
Revenue growth 3Y4.68%
Revenue growth 5Y2.13%
Sales Q2Q%11.25%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 64.50, which means the current valuation is very expensive for ATRI.
Based on the Price/Earnings ratio, ATRI is valued a bit cheaper than 68.06% of the companies in the same industry.
ATRI is valuated expensively when we compare the Price/Earnings ratio to 26.53, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
ATRI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ATRI is cheaper than 73.82% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ATRI is valued cheaper than 84.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.25 | ||
| EV/EBITDA | 26.01 |
4.3 Compensation for Growth
ATRI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
ATRI has a Yearly Dividend Yield of 1.91%. Purely for dividend investing, there may be better candidates out there.
ATRI's Dividend Yield is rather good when compared to the industry average which is at 1.89. ATRI pays more dividend than 96.34% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, ATRI has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.91% |
5.2 History
The dividend of ATRI is nicely growing with an annual growth rate of 10.99%!
ATRI has been paying a dividend for at least 10 years, so it has a reliable track record.
ATRI has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.99%
Div Incr Years20
Div Non Decr Years20
5.3 Sustainability
ATRI pays out 123.31% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of ATRI has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP123.31%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:ATRI (8/20/2024, 8:22:19 PM)
459.92
+0.26 (+0.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners1.01%
Inst Owner Change-45.73%
Ins Owners1.03%
Ins Owner Change0%
Market Cap809.46M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.91% |
Yearly Dividend8.6
Dividend Growth(5Y)10.99%
DP123.31%
Div Incr Years20
Div Non Decr Years20
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.5 | ||
| Fwd PE | N/A | ||
| P/S | 4.46 | ||
| P/FCF | 29.25 | ||
| P/OCF | 20.89 | ||
| P/B | 3.39 | ||
| P/tB | 3.55 | ||
| EV/EBITDA | 26.01 |
EPS(TTM)7.13
EY1.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)15.73
FCFY3.42%
OCF(TTM)22.02
OCFY4.79%
SpS103.18
BVpS135.72
TBVpS129.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.82% | ||
| ROE | 5.26% | ||
| ROCE | 5.93% | ||
| ROIC | 5.13% | ||
| ROICexc | 5.53% | ||
| ROICexgc | 5.81% | ||
| OM | 7.93% | ||
| PM (TTM) | 6.92% | ||
| GM | 32.08% | ||
| FCFM | 15.24% |
ROA(3y)11.02%
ROA(5y)11.82%
ROE(3y)12.05%
ROE(5y)13%
ROIC(3y)11.35%
ROIC(5y)12.04%
ROICexc(3y)13.26%
ROICexc(5y)14.73%
ROICexgc(3y)13.99%
ROICexgc(5y)15.58%
ROCE(3y)13.12%
ROCE(5y)13.92%
ROICexcg growth 3Y-18.15%
ROICexcg growth 5Y-19.86%
ROICexc growth 3Y-17.93%
ROICexc growth 5Y-19.35%
OM growth 3Y-18%
OM growth 5Y-13.39%
PM growth 3Y-19.22%
PM growth 5Y-12.62%
GM growth 3Y-6.34%
GM growth 5Y-4.8%
F-Score6
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 70.13% | ||
| Cap/Sales | 6.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 128.3% | ||
| Profit Quality | 220.39% | ||
| Current Ratio | 6.8 | ||
| Quick Ratio | 2.94 | ||
| Altman-Z | 25.99 |
F-Score6
WACC8.7%
ROIC/WACC0.59
Cap/Depr(3y)171.65%
Cap/Depr(5y)178.27%
Cap/Sales(3y)13.72%
Cap/Sales(5y)13.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.54%
EPS 3Y-14.81%
EPS 5Y-9.39%
EPS Q2Q%-93.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6%
Revenue growth 3Y4.68%
Revenue growth 5Y2.13%
Sales Q2Q%11.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.38%
EBIT growth 3Y-14.16%
EBIT growth 5Y-11.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.73%
OCF growth 3Y-20.1%
OCF growth 5Y-14.29%